OrthoPediatrics (KIDS) Misses Q2 EPS by 7c, Revenue Beats

OrthoPediatrics (NASDAQ: KIDS) reported Q2 EPS of ($0.21), $0.07 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $15.1 million versus the consensus estimate of $14.24 million.

Guidance:

OrthoPediatrics is providing financial guidance for the full year 2018, as follows:

Revenue growth in a range of 23% to 24% year-over-year, up from prior guidance of 22%.
Consigned set investments of approximately $11.0 million, up from prior guidance of $10.0 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Greenlane Holdings Inc. (GNLN) reported Q2 result
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13